SPATA31A1
gene geneOn this page
Also known as DKFZP434B204C9orf36A
Summary
SPATA31A1 (SPATA31 subfamily A member 1, HGNC:23394) is a protein-coding gene on chromosome 9p12, encoding Spermatogenesis-associated protein 31A1 (Q5TZJ5). May play a role in spermatogenesis.
Predicted to be involved in cell differentiation and spermatogenesis. Predicted to be located in membrane.
Source: NCBI Gene 647060 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 158 total
- MANE Select transcript:
NM_001085452
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23394 |
| Approved symbol | SPATA31A1 |
| Name | SPATA31 subfamily A member 1 |
| Location | 9p12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZP434B204, C9orf36A |
| Ensembl gene | ENSG00000204849 |
| Ensembl biotype | protein_coding |
| OMIM | 621335 |
| Entrez | 647060 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000377647, ENST00000473440
RefSeq mRNA: 1 — MANE Select: NM_001085452
NM_001085452
CCDS: CCDS43808
Canonical transcript exons
ENST00000377647 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001669893 | 39357132 | 39357189 |
| ENSE00001674055 | 39355669 | 39355919 |
| ENSE00001869390 | 39358074 | 39361962 |
| ENSE00003658890 | 39357758 | 39357818 |
Expression profiles
Bgee: expression breadth tissue_specific, 10 present calls, max score 71.20.
Top tissues by expression
121 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 71.20 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 70.88 | gold quality |
| right testis | UBERON:0004534 | 70.88 | gold quality |
| testis | UBERON:0000473 | 70.52 | gold quality |
| cortical plate | UBERON:0005343 | 39.93 | gold quality |
| sural nerve | UBERON:0015488 | 39.45 | gold quality |
| bone marrow cell | CL:0002092 | 38.01 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.36 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 35.34 | silver quality |
| muscle tissue | UBERON:0002385 | 33.25 | gold quality |
| bone marrow | UBERON:0002371 | 32.69 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| urinary bladder | UBERON:0001255 | 30.85 | silver quality |
| liver | UBERON:0002107 | 30.10 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.65 | gold quality |
| monocyte | CL:0000576 | 29.46 | gold quality |
| blood | UBERON:0000178 | 29.42 | silver quality |
| leukocyte | CL:0000738 | 29.30 | gold quality |
| lymph node | UBERON:0000029 | 28.73 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| right lobe of liver | UBERON:0001114 | 27.08 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| endocervix | UBERON:0000458 | 26.08 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.31 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
20 targeting SPATA31A1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-519A-2-5P | 98.78 | 71.74 | 1401 |
| HSA-MIR-520B-5P | 98.78 | 71.74 | 1401 |
| HSA-MIR-4536-5P | 98.47 | 64.39 | 657 |
| HSA-MIR-4684-5P | 98.29 | 67.99 | 1650 |
| HSA-MIR-6810-5P | 98.29 | 66.21 | 975 |
| HSA-MIR-7113-5P | 97.88 | 67.33 | 1735 |
| HSA-MIR-376C-3P | 97.63 | 68.88 | 1263 |
| HSA-MIR-5586-3P | 95.51 | 67.00 | 805 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spata31 | ENSMUSG00000056223 |
| rattus_norvegicus | Spata31 | ENSRNOG00000018202 |
Paralogs (13): SPATA31C2 (ENSG00000177910), SPATA31E1 (ENSG00000177992), SPATA31A6 (ENSG00000185775), SPATA31D3 (ENSG00000186788), SPATA31F3 (ENSG00000187791), SPATA31D4 (ENSG00000189357), SPATA31F1 (ENSG00000205108), SPATA31D1 (ENSG00000214929), SPATA31C1 (ENSG00000230246), (ENSG00000251545), SPATA31A3 (ENSG00000275969), SPATA31A7 (ENSG00000276040), SPATA31A5 (ENSG00000276581)
Protein
Protein identifiers
Spermatogenesis-associated protein 31A1 — Q5TZJ5 (reviewed: Q5TZJ5)
Alternative names: Protein FAM75A1
All UniProt accessions (1): Q5TZJ5
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in spermatogenesis.
Subcellular location. Membrane.
Similarity. Belongs to the SPATA31 family.
RefSeq proteins (1): NP_001078921* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027970 | SPATA31-like | Domain |
| IPR039509 | SPATA31 | Domain |
Pfam: PF14650, PF15371
UniProt features (19 total): compositionally biased region 7, region of interest 6, sequence conflict 4, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5TZJ5-F1 | 38.42 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 14 (showing top):
GOBP_MALE_GAMETE_GENERATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, chr9p12, BRCA1_DN.V1_DN, MIR548D_3P, MIR548H_3P_MIR548Z, MIR548BB_3P, MIR548AC, MIR519A_2_5P_MIR520B_5P, MIR4684_5P, MIR5586_3P, GOBP_SEXUAL_REPRODUCTION, GOBP_REPRODUCTIVE_PROCESS, GOBP_MULTICELLULAR_ORGANISMAL_REPRODUCTIVE_PROCESS
GO Biological Process (2): spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
120 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPATA31A1 | LRRC63 | Q05C16 | 597 |
| SPATA31A1 | ANKRD60 | Q9BZ19 | 571 |
| SPATA31A1 | CCDC74B | Q96LY2 | 541 |
| SPATA31A1 | FAM47C | Q5HY64 | 507 |
| SPATA31A1 | C12orf42 | Q96LP6 | 506 |
| SPATA31A1 | TTLL8 | A6PVC2 | 480 |
| SPATA31A1 | A6NGT6 | A6NGT6 | 477 |
| SPATA31A1 | RBMY1J | Q15415 | 475 |
| SPATA31A1 | BAIAP2L2 | Q6UXY1 | 374 |
| SPATA31A1 | CNTNAP3 | Q9BZ76 | 371 |
| SPATA31A1 | INPP5F | Q9Y2H2 | 370 |
| SPATA31A1 | KRT78 | Q8N1N4 | 350 |
| SPATA31A1 | KRT79 | Q5XKE5 | 348 |
| SPATA31A1 | CTU1 | Q7Z7A3 | 336 |
| SPATA31A1 | WDPCP | O95876 | 317 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A096LP49, A6NGG8, A6NNH2, B1ASB6, B4DYI2, B6VQA5, C0HKD1, C0HKD2, C0HKD3, D2J0Y4, D6RGX4, E9QAF0, P0C874, P0DKV0, Q149B8, Q3KR64, Q4R736, Q4V8B5, Q5TZJ5, Q5VU36, Q5VVP1, Q5VWK0, Q5VYM1, Q5VYP0, Q63HN1, Q658T7, Q68A65, Q6NS69, Q6NXZ1, Q6PAC4, Q6ZQQ2, Q6ZU69, Q6ZUB0, Q6ZUB1, Q7TSA6, Q80X53, Q86Y26, Q8BHP2, Q8BHW6, Q8C0D9
Diamond homologs: B4DYI2, B6VQA5, E9QAF0, P0C874, P0DKV0, Q5TZJ5, Q5VU36, Q5VVP1, Q5VYP0, Q6ZQQ2, Q6ZUB0, Q6ZUB1, Q8IWB4, A6NFR6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
158 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 132 |
| Likely benign | 25 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1124 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:39357081:A:C | acceptor_gain | 1.0000 |
| 9:39357083:T:G | acceptor_gain | 1.0000 |
| 9:39357086:T:A | acceptor_gain | 1.0000 |
| 9:39357076:A:AG | acceptor_gain | 0.9900 |
| 9:39357076:A:T | acceptor_gain | 0.9900 |
| 9:39357077:C:CT | acceptor_gain | 0.9900 |
| 9:39357077:T:G | acceptor_gain | 0.9900 |
| 9:39357078:T:A | acceptor_gain | 0.9900 |
| 9:39357082:A:AG | acceptor_gain | 0.9900 |
| 9:39357082:ATCTT:A | acceptor_gain | 0.9900 |
| 9:39357084:A:T | acceptor_gain | 0.9900 |
| 9:39357093:C:CT | acceptor_gain | 0.9900 |
| 9:39357094:C:CA | acceptor_gain | 0.9900 |
| 9:39357095:C:CT | acceptor_gain | 0.9900 |
| 9:39357096:C:CA | acceptor_gain | 0.9900 |
| 9:39357112:G:C | acceptor_gain | 0.9900 |
| 9:39357114:C:G | acceptor_gain | 0.9900 |
| 9:39357755:C:CC | acceptor_gain | 0.9900 |
| 9:39357756:A:AG | acceptor_gain | 0.9900 |
| 9:39357757:G:GG | acceptor_gain | 0.9900 |
| 9:39355918:C:G | donor_loss | 0.9800 |
| 9:39355918:CCTTT:C | donor_gain | 0.9800 |
| 9:39355919:ACCTT:A | donor_loss | 0.9800 |
| 9:39355920:TA:T | donor_loss | 0.9800 |
| 9:39355921:TTACC:T | donor_loss | 0.9800 |
| 9:39355922:CTTAC:C | donor_loss | 0.9800 |
| 9:39355923:CCTTA:C | donor_loss | 0.9800 |
| 9:39357075:A:AC | acceptor_gain | 0.9800 |
| 9:39357075:A:C | acceptor_gain | 0.9800 |
| 9:39357076:ATT:A | acceptor_gain | 0.9800 |
AlphaMissense
8805 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:39359011:T:C | F416L | 0.975 |
| 9:39359013:C:A | F416L | 0.975 |
| 9:39359013:C:G | F416L | 0.975 |
| 9:39359039:A:T | E425V | 0.933 |
| 9:39359017:G:C | G418R | 0.931 |
| 9:39359104:T:C | F447L | 0.914 |
| 9:39359106:C:A | F447L | 0.914 |
| 9:39359106:C:G | F447L | 0.914 |
| 9:39359040:G:C | E425D | 0.912 |
| 9:39359040:G:T | E425D | 0.912 |
| 9:39359041:T:C | S426P | 0.897 |
| 9:39359014:T:A | W417R | 0.892 |
| 9:39359014:T:C | W417R | 0.892 |
| 9:39360136:T:C | F791L | 0.890 |
| 9:39360138:C:A | F791L | 0.890 |
| 9:39360138:C:G | F791L | 0.890 |
| 9:39360202:T:A | W813R | 0.878 |
| 9:39360202:T:C | W813R | 0.878 |
| 9:39359035:A:C | S424R | 0.861 |
| 9:39359037:C:A | S424R | 0.861 |
| 9:39359037:C:G | S424R | 0.861 |
| 9:39360204:G:C | W813C | 0.854 |
| 9:39360204:G:T | W813C | 0.854 |
| 9:39359039:A:G | E425G | 0.849 |
| 9:39359012:T:C | F416S | 0.848 |
| 9:39359034:C:A | H423Q | 0.840 |
| 9:39359034:C:G | H423Q | 0.840 |
| 9:39359017:G:T | G418C | 0.835 |
| 9:39359039:A:C | E425A | 0.827 |
| 9:39359470:T:C | F569L | 0.822 |
dbSNP variants (sampled 300 via entrez): RS1001159299 (9:39361363 T>C,G), RS1001507197 (9:39361110 G>A), RS1002223515 (9:39359187 T>C), RS1003280555 (9:39355379 C>T), RS1004672962 (9:39361994 G>A,C,T), RS1005516442 (9:39358747 G>A,T), RS1006089296 (9:39357628 G>A,T), RS1007460772 (9:39355529 T>A,C), RS1007517291 (9:39356702 C>T), RS1010169108 (9:39361355 C>G), RS1010755315 (9:39356455 G>A,C), RS10125162 (9:39358957 C>T), RS1016130585 (9:39361676 G>A), RS1016391066 (9:39362012 A>G), RS1017446429 (9:39359075 C>A,T)
Disease associations
OMIM: gene MIM:621335 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007637_13 | Diffusing capacity of carbon monoxide | 3.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009369 | diffusing capacity of the lung for carbon monoxide |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
1 total (human), top 1 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.